RFHIC Corp., a manufacturer of active RF and MW components and hybrids for wireless telecommunication markets, released Hyperthermia treatment or RF ablation purpose RF amplifier. This pallet amplifier uses GaN-on-SiC technology that is very robust against back power or other damages, and reduces the need for maintenance.

Early stages of a cancer treatment often use this effective RF technology to treat patients. This highly efficient power amplifier use 2.3 to 2.5 GHz frequency, and has a 200 W output power, and three-stage amplifier design totaling 31 dB gain. Final stage amplifier has 55 percent efficiency when operated at AB class amplification. When using the power amplifier on an E-class amplification, the efficiency reaches 90 percent efficiency.

“Much has been said on cancer treatment by RF technology, and many research results show hard evidence that this actually works and is better than traditional medical surgery," said Kevin Kim, Senior International Sales Manager, RFHIC Corp. "Recent post from Samsung Medical Center (SMC) comments that radio frequency ablation, or RFA, treatment has proved to be the most effective and the safest approach to destroying inoperable early-stage tumors in the liver. RFHIC is proud to support such an industry with high performance RF amplifiers.”